Zomedica (ZOM) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
21 Apr, 2026Strategic vision and technology innovation
Focus on advancing animal health through practical innovation and expanding digital capabilities, with technology and AI central to growth and improved clinical outcomes.
Five pillars guide decisions: improving pet care, enhancing pet parent satisfaction, streamlining veterinary workflow, supporting veterinarian cash flow, and increasing clinic profitability.
Investment in connected devices, cloud platforms, and AI to unify diagnostics, data, and clinical workflows for better insights and services.
Market trends and digital transformation
AI in animal health projected to grow from $1.57B in 2024 to $7B by 2033, with pet tech and telehealth markets also expanding rapidly.
Zomedica's digital transformation includes MyZomedica platform, mobile apps, e-commerce, and over-the-air software updates, supporting scalable growth.
TRUVIEW AI integration and PIMS (Patient Information Management System) connectivity are key enhancements for workflow and data integration.
Financial performance and guidance
Fourth quarter of 2025 expected to be a record, marking the 20th consecutive quarter of year-on-year revenue growth.
Break-even projected at $55M annualized revenue, with profitability targeted by 2027.
Consumables account for 70-73% of revenue, supporting a recurring revenue model.
Significant operating leverage expected as revenue grows beyond break-even, with no major CapEx needed for current manufacturing scale.
Latest events from Zomedica
- Record Q2 revenue up 37% year-over-year, net loss down 49%, and strong liquidity supports growth.ZOM
Q2 2026 - Five-pillar sales strategy and cross-selling drive strong revenue growth and expanding market presence.ZOM
Investor update - Five Pillars strategy fuels recurring revenue, efficiency, and global growth toward profitability.ZOM
Investor update - Q1 2026 revenue up 35% to $8.8M, with strong margins, lower losses, and improved cash burn.ZOM
Q1 2026 - Strong growth and innovation in animal health technology drive expanding market leadership.ZOM
Investor presentation - Virtual meeting to vote on directors, auditor, executive pay, and by-law amendment; Board is majority independent.ZOM
Proxy filing - Virtual annual meeting to vote on directors, auditor, compensation, and by-law changes.ZOM
Proxy filing - Virtual meeting to vote on directors, auditor, executive pay, and by-law changes; board is majority independent.ZOM
Proxy filing - Record revenue growth and strong margins, with new segments and cost controls driving performance.ZOM
Q4 2025